Breast, bladder, colon, and ovarian carcinomas show frequent low level 20q gain and less frequently high level 20q13.2 ampli®cation, but the signi®cance of these 20q ampli®cations in transformation has not been de®ned. 
Introduction
It has long been known that most cancers have both random and nonrandom chromosome defects (Yunis, 1982) . Single copy chromosome losses and gains, have been identi®ed in many human cancer types (Sandberg and Berger, 1994) . Homogeneous staining regions (HSRs), expanded chromosome regions (ECRs), and double minute chromosomes (DMs), all indicative of gene ampli®cation, are also frequently seen in human tumors and are considered the principle genetic structures on which oncogenes and genes for drug resistance are located (Hahn, 1993) . Comparative genomic hybridization (CGH) has been particularly useful in identi®cation of the chromosome regions ampli®ed in human cancers (Gray and Pinkel, 1991; Kallioniemi et al., 1992; 1994a) . Relevant to the present report, CGH has revealed ampli®cation of 20q sequences in many human cancer types including: breast cancer (Kallioniemi et al., 1994b; Muleris et al., 1994) ; bladder cancer ; colon carcinoma (Schlegel, 1995) ; ovarian cancer (Iwabuchi, 1995) , and glioma (Mohapatra et al., 1995) . While low level ampli®cation occurs most frequently in these cancers, high level 20q ampli®cation also has been reported and usually includes the 20q13.2 region. For example, high level 20q ampli®cation at 20q13.2 occurs in breast cancer (Tanner et al., 1995) , and is included in the 20q12-4qter region ampli®ed in bladder cancer . The critical region of ampli®cation in human breast cancers has been further narrowed to *1.5 megabases in the 20q13.2 region (Tanner et al., 1994) . Several genes, including TOPOI, and SRC, have been ruled out as the putative 20q13.2 breast cancer oncogene, based on their physical distance from RMC20C001, the cosmid probe thought to lie at the center of the 20q13.2 breast cancer amplicon (Tanner et al., 1994) .
Recently, a series of human tumor cell lines were examined for evidence of CAS ampli®cation . The CAS (cellular apoptosis susceptibility) gene was isolated as a result of a genetic screen for cDNAs that would render cancer cells resistant to bacterial toxins and immunotoxins. CAS, which maps to 20q13.2, is the human homolog of the yeast chromosome segregation gene, CSE1 (Xiao et al., 1993) . The CSE1 gene product is a microtubule protein involved in chromosome spindle formation; CSE1 mutations lead to a chromosome segregation deficiency phenotype in yeast (Xiao et al., 1993; Scherf et al., 1996) . Based on its homology to CSE1, it is reasonable to hypothesize that CAS might play a role in chromosome segregation in human cells. Results showed that CAS is ampli®ed, usually two-to threefold, in a number of breast cancer, colon cancer, and leukemia cell lines (Brinkman et al., 1996) . One breast cancer cell line, BT-474, showed three-to eightfold CAS ampli®cation and translocation of CAS to other chromosomes . However, because CAS maps centromeric to RMC20C001 which is at the center of the breast cancer amplicon, it has been proposed that CAS is probably not the critical breast cancer gene, but may be co-ampli®ed with it .
Very little is known about the phenotype resulting either from single copy 20q gain or from high level 20q13.2 ampli®cation in transformation of human cells in vivo or in vitro. Low level ampli®cation of 20q has been correlated with early stage ovarian cancer (Iwabuchi et al., 1995) . In contrast, high level ampli®cation of the minimal 20q13.2 breast cancer amplicon correlates with a poor clinical prognosis in patients with node negative breast cancer, suggesting a role for ampli®cation of the putative 20q13.2 oncogene(s) in tumor progression (Tanner et al., 1995) . The biological signi®cance of 20q gains in transformation of human epithelial cells is essentially unknown.
In the current paper, we present data that elucidate the biological signi®cance of 20q ampli®cation in transformation of a relevant human epithelial cell type. We used an in vitro human uroepithelial cell (HUC) transformation system (Rezniko et al., 1996a) . As noted above, gain of 20q has been observed in clinical bladder cancers. We previously reported that immortalization of HUC after transformation with Human Papillomavirus 16 (HPV16) E7 or E6 rarely occurs ( 51610 75 ) (Belair et al., 1996) and, when it does occur, is always associated with chromosome changes (Rezniko et al., 1994) . We observed that two independent E7-transformed HUCs had a clonal marker containing extra 20q material. We also observed that the clonal marker chromosome containing the extra chromosome 20 material remained stable in culture, as did the whole karyotype (Rezniko et al., 1994) . Immortalization of E6-transformed HUCs was also associated with chromosome alterations. However, in contrast to E7-immortal HUCs, E6-immortal HUCs always showed chromosome instability. Because E6 leads to p53 degradation, we concluded that our results were consistent with the hypothesis that p53 loss leads to chromosome instability (White et al., 1994) .
We have now extended our analysis of genetic alterations and phenotypes in E7-immortalized HUCs to include results of analyses of six independent cell lines from ®ve dierent tissue samples. We can now report for the ®rst time a statistically signi®cant association between single copy 20q gain and immortalization of HPV16 E7 transformed HUCs (Pvalue=2610 77 ). We also report for the ®rst time an association between high level 20q13.2 ampli®cation and genome instability. Since these cells have only wildtype p53, these data suggest that 20q gain may represent an alternate pathway to genome instability. These results have profound signi®cance for understanding the role of 20q gains in the pathogenesis and prognosis of many human cancer types.
Results

Association of 20q gain with immortalization of E7 transformed HUCs
Normal HUC transformed with HPV16 E7 reproducibly show an extended lifespan, but rarely form immortal cell lines (Rezniko et al., 1994; Belair et al., 1996) . When such cells do immortalize, this usually occurs after an extended crisis period of undetectable cell proliferation. To test the hypothesis that nonrandom genetic alteration(s) may be required for immortalization of E7-transformed HUCs, cytogenetic analysis was done at relatively early passage (P) on six newly established E7-HUC lines (aE7-1, aE7-2, dE7-1, eE7-1, gE7-1, and yE7-1) from ®ve independent tissue sources after a proliferative population of cells emerged from the crisis (Table 1) .
Results showed near diploid chromosome numbers in all E7-HUC lines. However, all of the lines contained one or several cytogenetic alterations (Table 1) . Five of six cell lines were clonal by cytogenetic analysis, as determined by the presence of a unique clonal chromosome marker in every cell at the earliest passage examined (Figure 1, insets) . In four E7-HUCs, dE7-1, eE7-1, gE7-1, and yE7-1, cytogenetic analysis indicated that the clonal marker contained 20q material (Table 1) . The clonal marker in the two lines previously analysed (i.e., aE7-1 and aE7-2) also contained 20q material by FISH analysis (Rezniko et al., 1994) . One of the new lines, yE7-1, contained four clones by cytogenetic analysis, and each of the four clones had an extra copy of chromosome 20 or 20q. CGH con®rmed the presence of low level (single copy) 20q11-4qter ampli®cation in all the E7-HUC lines (Table 1 and Figure 2 ). FISH with whole chromosome paint con®rmed the presence of chromosome 20q material on all the clonal markers ( Figure 1) . Finally, Southern analysis with a probe for HPV16 E6/ E7 showed that ®ve of six cell lines contained a single unique insertion site and were therefore clonal and 20q gain in human uroepithelial cell transformation E Savelieva et al independent in origin ( Figure 3 ). The remaining cell line, yE7-1, showed four independent unique insertions, consistent with the cytogenetic analyses that revealed four distinct clonal populations. Statistical analysis was done to test the hypothesis that the gain of 20q in association with immortalization could have occurred by chance in this series of E7-HUCs. For this analysis, only the cell lines that had been completely karyotyped were used (Table 1) . This included the ®ve clonal cell lines and the dominant clone in the nonclonal line (Table 1) . Results showed that the association between 20q gain and immortalization was highly signi®cant (P-value=2610
77
) and unlikely to occur by chance. Notably, this analysis underestimated the signi®cance of the ®nding, as three other clones in the yE7-1 line also showed 20q gain. The signi®cance of 10p12.1-4pter loss was also tested. Results showed that 10p loss was important with a P-value of 3610
75
. This ®nding suggests that a 10p loss also contributes to E7 HUC immortalization. Several other alterations occurred in more than one cell line. Two cell lines showed clonal gain of 9q12-4q13, and two cell lines showed clonal gain of whole chromosome 5 (Table 1) . CGH showed additional less important alterations in some cell lines that were not clonally present in the karyotype (Table 1) Table 1 ). When these cell lines were examined at early passage after staining with whole chromosome 20 paint, it was observed that both lines contained additional chromosome 20 material (add 20) , and that these add 20 signals were on other chromosomes ( Figure 1C and 1E, arrowheads). The number of add 20 signals varied among the cells in the cultures in both cell lines (Table 2 ). In addition, it was noted that the marker chromosome in both of these cell lines was unstable. For example, the marker chromosome in dE7-1 was originally indistinguishable from a normal chromosome 20, but lengthened in culture forming a large expanded chromosome regions (ECR) (Figure 4a ). The marker chromosome in gE7-1 showed breakage ( Figure 5D and insert, as discussed below). Sometimes the add 20 signals formed distinct`zebra-like' patterns, suggesting a breakage and recombination type mechanism ( Figure  4b ). The normal copies of chromosome 20 remained stable in all the cell lines, as determined by FISH and Giemsa staining ( Figure 1 ).
Both dE7-1 and gE7-1, the two cell lines with 20q13.2 ampli®cation, contained double minute chromosomes (DMs), as well as ECRs (Table 2) . FISH showed that some, but not all, of the DMs stained with whole chromosome 20 paint ( Figure 4C ). The number of DMs per cell varied from a few to hundreds per cell (data not shown). One cell line, namely eE7-1, contained DMs in a few cells, but no ECRs or add 20 signals (Table 2) . A later passage of this line was not studied to determine if instability or ampli®cation involving chromosome 20q developed.
In addition, consistent with the detection of 8q21.2 ?q23 ampli®cation by CGH in dE7-1 (Table 1) , DMs and ECRs in dE7-1 also stained with chromosome 8 Figure 2 Quantitative CGH digital image analyses for chromosome 20 in E7-HUCs. These data show a common single copy gain of 20q1-4qter in all E7-HUCs at the earliest passage studied. One cell line, gE7-1 at P25, shows a peak of ampli®cation of 20q13.1-4q13.2. Another cell line, d E7-1 at P25, shows a peak at 20q13.2
Controls E7-HUCs
CaSki HUC α-1 α-2 δ-1 ε-1 γ-1 θ-1 Figure 3 Southern analysis for HPV16 insertions sites in Eu7-HUCs. Southern analysis was done using HindIII-digested DNA from the six cell lines. The CaSki cell line that contains approximately 600 copies of HPV16 was used as a positive control. All the lines, except yE7-1 contains a single insertion 20q gain in human uroepithelial cell transformation E Savelieva et al paint, although less frequently than with chromosome 20 paint ( Figure 4D ), suggesting instability of the ampli®ed 8q region.
E7-HUCs show high ampli®cation in the reigon of the 20q13.2 breast cancer amplicon
To test whether the 20q13.2 ampli®cation that was observed in dE7-1 and gE7-1 included the same region ampli®ed in human breast cancers, FISH was done using two 20q13.2 probes (LS1, a P1 and 11268, a cosmid) that map near the center of the breast cancer amplicon. A P1 probe containing CAS was also used because it maps to 20q13.2 and because CAS alterations theoretically could lead to genome instability, as discussed above. Two P1 probes (E2F and 3916) that map to 20q11.2, a region that showed only low level ampli®cation by CGH in all the E7-HUCs, were also used. Results using both E2F and 3916 showed only one signal on each copy of the normal 20 chromosomes and one signal on the 20q marker(s) in ®ve of the six cell lines (Tables 2 and 3) , as illustrated by results with dE7-1 (Figures 1C and 5A ). This would be the expected result if after chromosome marker formation, no ampli®cation or further rearrangements involving this region occurred. The sixth cell line, gE7-1, showed one signal on the single normal chromosome 20 present, but had three signals on the marker (Compare Figures  1E, and 5C , and see Table 3 ), representing modest ampli®cation.
Results showed that the two cell lines, namely dE7-1 and gE7-1 that at P25 showed 20q13.2 ampli®cation by CGH (Figure 2 ) also showed high level ampli®cation with both probes that mapped near the center of the breast cancer amplicon (Table 3) . For example, dE7-1 P25 showed as many as nine signals per cell with both probes (Table 3 and Figure 5B), and gE7-1 showed as many as 15 signals per cell (Table 3 and Figure 5D ). Interestingly, the ampli®cation of the 20q13.2 sequences usually was noted to occur on the marker chromosome (compare Figures 1C and 5B and Figures 1E and 5D, insert) . These marker chromosomes contained ECRs when examined using Giemsa stain ( Figure 1C and E inserts). Results using a P1 probe containing CAS, also at 20q13.2, showed 3 ± 7 signals in both E7-HUCs that had 20q13.2 ampli®cation ( T h e a n a (Table 2) , consistent with the above hypothesis. In addition, we compared the number of signals using the breast cancer amplicon probes at early and late passage. Once again, results were consistent with the hypothesis that ampli®cation of a gene in this region may give cells a growth advantage (Table 3) .
E7-HUCs showing genome instability and 20q13.2 ampli®cation contain only wildtype TP53 sequences
Two E7-HUC lines, dE7-1 and gE7-1, manifested numerous parameters of genome instability that have been associated with p53 alteration. These parameters of instability included single copy chromosome losses and gains, chromosome region ampli®cation, chromosome rearrangements and translocations, DMs, and ECRs (Figures 1, 2 , 4 and 5, Tables 1 ± 3 ). Cells with 20q13.2 ampli®cation also showed numerous examples of other structural chromosome anomalies including chromatid exchanges (CTE), chromatid gaps (CTG), chromosome breaks (CBS), acentric chromosomes (ACEs), and large marker chromosomes ( Figure 6 ). To determine if this genome instability phenotype could be attributed to acquisition in culture of p53 alteration, TP53 was sequenced in all six of the E7-HUC lines at passages similar or later than those used for the cytogenetic analyses. Sequencing data showed only wildtype sequences in exons 5 ± 9, a result that fails to support the above hypothesis.
Discussion
The observation that low and/or high level amplification of 20q occurs frequently in breast cancer, bladder cancer, colon cancer, ovarian cancer, and glioma suggests that gain of a gene or genes on 20q contributes to the development of and/or progression of these human cancer types. Thus, it is of great importance both to identify the site(s) on 20q in which such gene(s) are located and to de®ne the biological consequence of their ampli®cation. In the present report, we present data which for the ®rst time associate a low level ampli®cation (single copy gain) ) between a minimal single copy gain of 20q and immortalization of a representative human epithelial cell type, HUC. Notably, HUC represent a relevant cell type for these studies because 20q gains are seen in bladder cancers . We and others have reported that transformation of human epithelial cells including; bladder, breast, bronchial, cervical, skin, and prostate by HPV16 E6 or HPV16 E7 reproducibly results in an extended lifespan before cellular senescence occurs, but that immortalization rarely occurs (reviewed in Belair et al., 1996) . This result has been interpreted to signify that the alterations resulting from E6 and/or E7 oncoprotein functions are insucient for overcoming the senescence block (e.g., Shay et al., 1993; Rezniko et al., 1994) . We now suggest that single copy over-representation of a gene on 20q contributes to immortalization of E7-transformed HUCs. In our system, this single copy gain of 20q usually took the form of chromosome 20 trisomy, a 20q isochromosome, or a 20q translocation leading to a marker chromosome containing extra 20q material. Human breast, colon, and leukemia tumor cell lines with low level 20q gains all show the same types of single copy chromosome 20 gains and rearrangements, as recently reported .
Recent studies from our laboratory elucidate the nature of the genetic event(s) required for immortalization of HUCs. We reported that precrisis normal HUCs growing in culture show low, but detectable, levels of p16, while senescent HUC show highly elevated p16 levels (Rezniko et al., 1996b) . This new ®nding suggested to us that accumulation of CDKN2/p16, an inhibitor of cyclin D/cdks (Serrano et al., 1993; Kamb et al., 1994) , might play a role in senescence by causing G1 cell cycle block. Consistent with this hypothesis, we observed that six of six E6-immortalized HUCs showed p16 loss in association with cell line formation, and that this loss was usually associated with LOH CDKN2/p16 (Yeager et al., 1995 and Rezniko et al., 1996b) . The ®nding that p16 is elevated at senescence in HUCs helped us to interpret an earlier observation made in our laboratory, namely that the levels of p16 were unexpectedly elevated in six of six independent immortal E7-HUCs (Yeager et al., 1995; Rezniko et al., 1996b) . We could now interpret this latter ®nding, at least in part, as retention of the elevated p16 levels associated with HUC senescence (Rezniko et al., 1996b) . In addition, these high levels may also have resulted from feedback regulation by pRB (Sherr and Roberts 1995) . We reasoned that such high levels of p16 should not be growth inhibitory in E7-transformed cells in which pRb is bound to and inactivated by the E7 oncoprotein. Thus, our data suggests at least two pathways to overcome the inhibitory eects of high levels of p16 at senescence. Nevertheless, just as with the E6 transformed cells which undergo an extended crisis prior to immortalization, E7 transformed cells also undergo a long crisis period prior to the emergence of immortal phenotype, suggesting a requirement for an additional genetic alteration(s).
We now report that all of six clonal, independent E7 immortalized HUC lines contained a single copy gain of 20q. This result leads us now to hypothesize that gain of one or more gene(s) on 20q contributes to immortalization of E7-transformed HUC. Whether this gene complements the action of the E7 oncoprotein (DeCaprio et al., 1988; Whyte et al., 1988 Figure 6 Shown here is an example of chromosome instability in a cell showing high level 20q13.2 ampli®cation (*24 copies) as determined by FISH staining with LS1. This cell contains many structural chromosome aberrations including; DMs, acentric chromosomes (ACE), chromatid gaps (CTG), chromosome breaks (CSB), chromatid exchanges (CTE), and large abnormal chromosomes (two large arrows). Note that some DMs and an acentric in this spread label with the LS1 20q13.2 probe 20q gain in human uroepithelial cell transformation E Savelieva et al ful®ls another function, such as reactivation of telomerase (Holt et al., 1996) , is at present unclear. The second major observation reported herein is that two of six immortal E7-HUC lines showed 20q13.2 ampli®cation and both of these cell lines showed genome instability. In contrast, two E7-HUC lines that maintained a stable clonal marker chromosome containing a single copy of 20q gain, showed chromosome stability in long-term culture, as previously reported (Rezniko et al., 1994) , and as con®rmed in these more detailed studies. Thus, a single 20q gain was not associated with genome instability in any of our studies. The types of chromosome instability observed in E7-HUCs with high level 20q13.2 ampli®cation included the appearance of DMs and ECRs (which are similar to homogeneous staining regions or HSRs, but show Gbanding). DMs, HSRs, and ECRs have been shown to contain ampli®ed genes in many studies (Hahn, 1993; Sandberg and Berger, 1994; Schimke, 1984) . The staining with whole chromosome 20 paint and 20q13.2 probes of ECRs and DMs in this study is consistent with the presence of ampli®ed 20q genes in these structures. The presence of DMs, HSRs, and ECRs in tumor cells has been shown to correlate with ampli®cation of oncogenes and/or ampli®cation of drug resistance genes, both of which would give cells a growth advantage in vivo and in vitro ± given appropriate selective conditions (Schimke, 1984; Hahn, 1993) . Our data indicate that E7-HUCs with ampli®ed 20q13.2 material have a growth advantage in vitro, as the percentage of such cells and the numbers of add 20 signals increased with passage in culture. This is consistent with apparent aggressiveness of breast cancer cells in vivo that have 20q13.2 amplification, and with the hypothesis that this region contains an ocogene (Tanner et al., 1995) .
Because our data suggest that the gene(s) on 20q that is ampli®ed plays a role in generating genome instability, we examined the status of CAS in our cell lines. We found CAS to be co-ampli®ed with the human breast cancer amplicon region in our lines, but to a lesser extent. Whether the co-ampli®cation of CAS or the putative 20q13.2 breast cancer oncogene is responsible for the genome instability observed in our cell lines is currently under investigation. A reasonable hypothesis is that 20q13.2 contains a cluster of genes that together may contribute to cancer development or progression. This is consistent with observations that large regions surrounding the center of the breast cancer amplicon are often co-ampli®ed in breast cancers (Tanner et al., 1995) .
We also tested the hypothesis that the chromosome instability seen in dE7-1 and gE7-1 in this study might have resulted from acquisition of a spontaneous TP53 mutation in culture. However, DNA sequencing showed only wildtype TP53 sequences in all six E7-HUCs, including the two cell lines with 20q13.2 ampli®cation and genomic instability, disproving this hypothesis. It has been proposed that p53 abnormalities play a role in generating genomic instability in primary human breast cancer (EyfjoÈ rd et al., 1995) . However, it is clear from these and other studies that alternate pathways exist for chromosome instability and gene ampli®cation (Livingstone et al., 1992) . The present data suggest that ampli®cation of a gene on 20q13.2 may represent such an alternate pathway to genetic instability.
It is not clear what mechanism led to the chromosome 20 ampli®cation, instability, and insertion into other chromosomes that was seen in E7-HUCs with 20q13.2 ampli®cation in our study (e.g., Figure 6 ). Possible models suggest that an early step in gene ampli®cation is the generation of DMs, which then reinsert into chromosomes to form HSRs or ECRs (Schimke, 1984; Hahn, 1993) . Such a mechanism would ®t our data, as both E7-HUCs with ECRs and add 20 signals by FISH contained DMs. It is interesting that the site of the initial genome ampli®cation and instability must have been the marker chromosome 20, as instability was never observed on the normal copies of chromosome 20.
The dE7-HUC cell lines also showed a peak of ampli®ed sequences at 8q21.2-4q23. This is notable because there are three examples of clinical cancers, namely human bladder cancer , human breast cancer (Kallioniemi et al., 1994b) , and human ovarian cancer (Iwabuchi et al., 1995) in which 20q13 and 8q21 are both ampli®ed. It is interesting that FISH studies with whole chromosome 8 paint showed that the ampli®ed 8q region followed the same pattern of instability as the ampli®ed 20q13.2, with the appearance of DMs, ECRs, and add 8 signals on other chromosomes. Furthermore, it is remarkable that this in vitro HUC transformation system recapitulates so faithfully the same combination of 8q and 20q ampli®cation that is seen in several clinical cancers. Finally, our data show loss of 10p in four of six E7-HUCs, indicating that a gene involved in immortalization may be located on this chromosome arm (P-values=3610 75 ), and also suggesting that a 20q gain may contribute to, but is insucient for immortalization.
In summary, these results suggest a model of malignant transformation for bladder, breast, and possibly other human epithelial cell types in which an early event associated with immortalization is a single copy gain of chromosome 20q, while a later event resulting in genome instability and progression is gene ampli®cation at 20q13.2. These ®ndings have profound implications for diagnosis and prognosis of many human cancer types, including breast, ovarian, and bladder cancers. In addition, this unique in vitro system, because of its close recapitulation of genetic alterations found in clinical cancers, may be valuable in identi®cation of candidate 20q oncogenes.
Materials and methods
Cell Culture
Primary explant cultures of HUC were established from residual ureter pieces from ®ve dierent kidney transplant donors (designated as a, b, g, e, y). HUC were grown on collagen-coated plastic dishes in 1% FBS-F12+, a supplemented Ham's F12 growth medium (GIBCO) with fetal bovine serum (FBS, SIGMA) (Rezniko et al., 1987) . HUCs were infected with retroviruses carrying HPV16 E7 (pLXSNE7) obtained from Dr Denise Galloway as described in Rezniko et al., 1994 . The establishment and characterization of the six immortal E7-HUC lines (aE7-1, aE7-2, dE7-1, eE7-1 gE7-1, and yE7-1) used have been described (Rezniko et al., 1994; Belair et al., 1996) . 
Southern blot analysis
High molecular weight DNA was isolated from log phase cultures by the guanidine isothiocyanate (Sigma) method (Rezniko et al., 1994) . Southern blot analysis to detect HPV16 E7 integrations was done on HindIII-digested DNAs which were transferred to a Hybond-N membrane (Amersham). The membrane was probed with a 0.8 kb PCR product containing HPV16 E6/E7 genes from the pLXSNE6/E7 plasmid. This probe was labeled with [a-32 P]dCTP using the Rediprime labeling kit (Amersham Life Sciences). CaSki cell line DNA, which contains multiple copies of HPV16, was used as a positive control.
Cytogenetic analysis
Karyotype analysis was done on trypsin-banded Leishmanstained metaphase chromosomes exactly as previously described (Rezniko et al., 1994) . Brie¯y, cells were arrested in metaphase by adding 0.14 mg/ml ethidium bromide (Sigma) for 15 min followed by 0.2 ng/ml colcemid (GIBCO). After a 3 h exposure, the cells were incubated for 7 min at room temperature with hypotonic solution (20:1 v/v; 75 mM KCl/8% sodium citrate). Cells were ®xed with a 3:1 methanol/acetic acid. Chromosome spreading was done on a humidi®ed slide warmer. For each chromosome analysis, 20 metaphase spreads were completely karyotyped.
Comparative genomic hybridization
Hybridization of dierentially labeled tumor and normal DNA to normal metaphase chromosomes was performed as described previously (Kallioniemi et al., 1994a) . Brie¯y, cell line DNA labeled with¯uorescein-dUTP and normal DNA labeled with Texas red-dUTP were hybridized to normal metaphase spreads which were then counter-stained with DAPI. Three-color images (DAPI,¯uorescein, Texas red) were collected from ®ve metaphases cells for each sample. Green and red¯uorescence intensities from pter to qter and the ratios of green to red intensity were calculated for each chromosome in the metaphase spread. In each metaphase cell the absolute¯uorescence intensities were normalized so that the average green to red ratio of all chromosomes in the metaphase was 1.0. The ®nal results were expressed as the mean green to red ratio pro®les+1 standard deviation, determined from two to three metaphase cells (four observations per chromosome). Only images that showed uniform high-intensity¯uorescence in both green and red colors, had no background spots, and in which the two chromatids showed the same changes, were evaluated.
Fluorescence in situ hybridization
FISH for chromosome 20 and chromosome 8 was performed using human 8 and 20 chromosome painting probes labeled with digoxigenin (Oncor). Dr Thomas Look at St Jude's Hospital performed FISH using an E2F probe on two cell lines. Drs Ira Pastan and Ulrich Brinkmann kindly provided the P1 probe containing CAS. Dr Jerey Trent of the National Center for Human Genome Research provided a biotin-labeled cosmid 11267, P1 3516, and an E2F probe. The P1 probes (3916, E2F, and CAS) were labeled by nick translation with digoxigenin-11-dUTP using the Oncor large fragment probe labeling kit. Optimal hybridizations were obtained when nick translated probes were between 300 and 600 bases long. The metaphase chromosome spreads were incubated in 26SCC for 30 min. Then the DNA on slides was denatured in a denaturation solution (70% formamide, 26SSC pH 7) at 708C for 2 min, followed by proteinase K digestion (0.05 mg/ml) at 378C for 7.5 min. The slides were dehydrated in an ethanol series and post-®xed in 3:1 methanol/acetic acid. For the hybridization mixture, 200 ± 300 ng P1 probe DNA was precipitated with 5 mg placental DNA and 5 mg Cot-1, then dissolved in a hybridization solution (50% formamide, 10% dextan sulfate, 26SSC at pH 7). The probe mixture was denatured for 10 min at 708C, pre-annealed at 378C for 1 h, and ®nally applied onto the metaphase slide. The slides were hybridized with probe for 24 h at 378C in a humidi®ed chamber. Then the slides were rinsed in a wash solution (50% formamide, 26SSC) at 43 ± 448C for 15 min, followed by washing in 26SSC at 388C for 8 min. Detection was done with Digoxigenin-FITC Detection Kit (Oncor) according the vendor protocol, which included one-step ampli®cation of signal with increased incubation time to 30 min for each step. Propidium Iodide was used as a counterstain for FITC-labeled probes. The P1 LSI 20q13.2 probe was labeled with Spectrum Orange by the vendor (Vysis). DAPI in antifade solution was used as a counterstain. The slides were examined with an Olympus BH-2 microscope with dual or triple band pass ®lter sets. For each cell line 50 metaphase spreads were examined to estimate the number of signals in each cell population per modal chromosome number.
TP53 DNA sequencing
Exons 5 through 9 of the p53 gene were ampli®ed in ®ve independent PCR reactions (one per exon) by Oncor Med Inc using DNAs prepared as described above. The PCR reactions were carried out using 100 ng DNA, 16con-centration of a proprietary reaction buer, 25 mmol dNTPs, 0.5U Taq Polymerase, and 70 ng each of a forward and reverse primer. The total reaction volume was 25 ml. Ampli®cation occurred in a MJ Research PTC-100 thermocycler under the following conditions: 5 min at 958C (denaturation); 35 cycles: of 30 s at 958C, 1.5 min at 588C, and 1.5 min at 708C; 1 cycle: 5 min at 708C. Ten percent of the PCR reaction was run on a 2% agarose gel to con®rm product size and ampli®cation. The reaction was puri®ed using Qiaquick Spin PCR Puri®cation Kit (Qiagen, Chatsworth, CA). The puri®ed PCR products were dye labeled using dye terminator cycle sequencing reactions with Amplitaq DNA Polymerase FS (Perkin Elmer, Foster City, CA). Conditions of cycle sequencing were followed per DNA sequencing kit protocol in a 9600 Perkin Elmer Thermocycler. Puri®cations of the dye attached PCR products were carried out on CentriSep Columns (Princeton Separations; Adelphia, NJ) and loaded onto a Perkin Elmer 377 Sequencer. The data was collected and analysed using Perkin Elmer's Data Collection Software (Version 1.1). The entire sequence of exons ®ve through nine as well as 10 to 20 bases 5' and 3' of each exon were analysed and compared to normal p53 sequence (Genebank).
Statistical analysis
The statistical signi®cance of clonal cytogenetic changes reported in Table 1 was assessed by calculating the probability of such extreme observations under an assumption of random change. For example, four of six cell lines showed loss on 10p, in the presence of a low rate of background loss. A random loss hypothesis gives each of the 39 evaluated chromosome arms equal probability of exhibiting loss. The reported P-value (3610 ±5 ) is the conditional probability that any one arm shows loss in 4 cell lines, given the number of loss events, under the random loss assumption. The 20q calculation is similar. In total over all the cell lines, there are nine additions at the level of a chromosome arm and six entire chromosome 20q gain in human uroepithelial cell transformation E Savelieva et al additions. Material on 20q is added eight times (taking only late passage d E7-1). The reported P-value (2610 77 ) is the conditional probability that any one arm is gained at least eight times, given the number of additions, under a random gain assumption.
